arrow
M

Michael P. DeMartino

GlaxoSmithKline
H指数:12
被引数:1,453

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2024-04-066
PRE
A small-molecule inhibitor of WRN selectively kills MSI-H cancer cells and phenocopies WRN genetic defects
2023-04-041
PRE
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel (vol 9, pg 1039, 2018)
2020-06-022
OAAI
Enteric RET inhibition attenuates gastrointestinal secretion and motility via cholinergic signaling in rat colonic mucosal preparations

肠RET抑制通过大鼠结肠粘膜制剂中的胆碱能信号减弱胃肠分泌和运动

2018-10-1217
OAAI
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel
2018-09-2629
OAAI
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS

发现一流的肠道限制性RET激酶抑制剂作为治疗IBS的临床候选药物

2018-05-2431
OAAI
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity

RIP3诱导凋亡,而与促凋亡激酶活性无关

2014-11-01540
OAAI